Ironwood Pharmaceuticals, Inc.

IRWDNASDAQHealthcare● Active

$3.29

$-0.02(-0.60%)

Market Cap$541576770

P/E Ratio—

52W High$5.78

52W Low$0.56

Avg Volume2.5M

Open$3.49

Beta0.24

Forecast Market Cap PE Ratio

Ironwood Pharmaceuticals, Inc.（IRWD）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

irwd · 股价预测 · 30 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 30 位华尔街分析师

Hold

30 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 30 · 买入占比: 36.7%

12 个月目标价

High

$5.70

Consensus

$4.80

+45.9% upside

Low

$3.70

Median: $5 · Last Close: $3.29

Ironwood Pharmaceuticals, Inc.（IRWD）的分析师共识为 Hold，基于过去 3 个月内 30 位华尔街分析师的评级。IRWD 的 12 个月平均目标价为 $4.80，相对当前价 $3.29 代表 +45.9% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $5 (45.9%)High $5.7Low $3.7

Consensus Target

$4.80

45.9% upside

High Target

$5.7

73.3%

Low Target

$3.7

12.5%

Current Price

$3.29

as of today

Based on analyst price targets, the IRWD stock price prediction for the next 12 months ranges from $3.7 to $5.7. The consensus IRWD price forecast of $4.80 implies 45.9% upside from the current price of $3.29.

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$3.13	↓ 5.00%	$3.10	$3.15

1-day model range: $3.1–$3.15. Peak: $3.15 (-5.00%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$2	$2	$2	-27.9%
2028	$2	$2	$2	-38.9%
2029	$2	$2	$2	-44.1%
2030	$2	$2	$2	-46.6%
2031	$2	—	$2	-48.0%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

7%7%86%

1Buy

1Neutral

12Sell

RSI (14)43.0Neutral

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · IRWD · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$3.30SELL

MA 10$3.48SELL

MA 20$3.64SELL

MA 50$3.85SELL

MA 100$3.98SELL

MA 200$3.17BUY

Current $IRWD · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$3.35SELL

EMA 10$3.45SELL

EMA 20$3.62SELL

EMA 50$3.77SELL

EMA 100$3.69SELL

EMA 200$3.37SELL

Current $IRWD · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2026-02-26	Citizens	Maintains	Market Outperform→Market Outperform
2026-01-05	Citizens	Upgrade ↑	Market Perform→Market Outperform
2026-01-05	Wells Fargo	Maintains	Equal Weight→Equal Weight
2025-11-11	Wells Fargo	Maintains	Equal Weight→Equal Weight
2025-04-15	Wells Fargo	Downgrade ↓	Overweight→Equal Weight
2025-04-15	Jefferies	Downgrade ↓	Buy→Hold
2025-04-14	Leerink Partners	Maintains	Market Perform→Market Perform
2025-01-30	JMP Securities	Maintains	Market Outperform→Market Outperform
2025-01-22	Craig-Hallum	Maintains	Buy→Buy
2024-08-09	Craig-Hallum	Maintains	Buy→Buy

Citizens2026-02-26

Maintains

Market Outperform→Market Outperform

Citizens2026-01-05

Upgrade ↑

Market Perform→Market Outperform

Wells Fargo2026-01-05

Maintains

Equal Weight→Equal Weight

Wells Fargo2025-11-11

Maintains

Equal Weight→Equal Weight

Wells Fargo2025-04-15

Downgrade ↓

Overweight→Equal Weight

Jefferies2025-04-15

Downgrade ↓

Buy→Hold

Leerink Partners2025-04-14

Maintains

Market Perform→Market Perform

JMP Securities2025-01-30

Maintains

Market Outperform→Market Outperform

Craig-Hallum2025-01-22

Maintains

Buy→Buy

Craig-Hallum2024-08-09

Maintains

Buy→Buy

Wall Street analysts have recently issued updated ratings on Ironwood Pharmaceuticals, Inc. (IRWD) stock. Of the recent 107 rating actions, 15 were upgrades and 19 were downgrades. 30 analysts currently cover IRWD.

分析师推荐趋势

Buy ratings2 → 1↓ 1

Hold ratings0 → 0

Sell ratings0 → 0

IRWD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$459M

↓ 6.0% YoY

Revenue Next Year

$478M

↑ 4.1% YoY

EPS This Year

$1.37

EPS Next Year

$1.40

↑ 2.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast IRWD EPS of $1.37 for the current fiscal year, based on estimates from 1 analysts. The IRWD revenue forecast is $459M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

IRWD 股价预测由两类独立数据源支撑：来自 30 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IRWD 的共识目标价为 $4.80（+45.9% 上行空间），分析师共识为 Hold。

IRWD 的短期预测（明日）为 $3.13（-5.00%）。 IRWD 对 2027 年的股价预测均值为 $2。 IRWD 对 2030 年的预测区间为 $2–$2。

Ironwood Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 IRWD。IRWD 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 37% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

IRWD 预测 · 8 个问题

根据 30 位华尔街分析师，IRWD 的 12 个月平均目标价为 $4.80，最高 $5.70、最低 $3.70。若有图表，中位目标价可在上方查看。相对当前价 $3.29，隐含约 +45.9% 的上行空间。

IRWD 目标价IRWD 分析师目标价IRWD 12个月目标价目标价 IRWD

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.